The whole friction of GLP-1 research has been the needle — reconstitution, syringes, cold chain, and a learning curve before the first dose. Two compounds in this catalog remove it entirely. Orforglipron is a non-peptide small molecule engineered from the start for oral bioavailability, and Prime also supplies Semaglutide in a 30-count capsule. Almost no research supplier stocks either one.
The original GLP-1 receptor agonist — the reference compound in metabolic research, now also available as an oral capsule and as a co-formulation with BPC-157.
A non-peptide small molecule GLP-1 receptor agonist built for oral bioavailability — no reconstitution, no needle, no cold chain.